Individualized Cardiac Index–Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery
Bernd Saugel, Agnes Sophia Meidert, Christian Sylvest Meyhoff, Rune Sort, Eske Kvanner Aasvang, Alina Bergholz, Abdelkader Serir, Eike Schwartze, Kristen K Thomsen, Christian Zöllner, Stephan Berthold, Melanie Borrmann, Joseph Esser, Anja Laska, Patrick Scheiermann, Nicolai Bang Foss, Jonathan Winther Olsen, Line Malmer Madsen, Anders H. Welling, Christine Gaik, Sebastian Roth, Julian Schröder, Marc Vives, Adam Klimovic, Michael Eichlseder, Sebastian Goldmann, Thomas Renné, Henrike Hedrich, Eik Vettorazzi, Antonia Zapf, Karim Kouz, Moritz Flick, PELICAN Trial Group, Linda Grüßer, Jan Larmann, Wiam Khader, Laima Balasova, Volker Huge, Anders P.H. Karlsen, Louise Bendix Kiel, Tobias Lyngeraa Wulff, Mikael R. Henriksen, Rasmus Beier Müller, Karin Graeser, Abdellatif El-Ahmadi, Marlene Søgaard, Melkorka Nørgaard, Mia Lind Jepsen, Øivind Jans, Morten Bundgaard and 10 more
Peer-reviewed journalReal-world use
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Conclusions and Relevance Among high-risk patients undergoing elective major abdominal surgery, individualized cardiac index–guided hemodynamic therapy targeting the patient’s preoperative resting cardiac index did not reduce the incidence of a composite outcome of acute kidney injury, acute myocardial injury, severe infectious complications, nonfatal cardiac arrest, or death within the first 7 postoperative days compared with routine hemodynamic therapy.
Here, authors develop a remote-activated dynamic biomimetic system for mechanical disruption of bacterial membranes and promotion of implant osteointegration for treatment of PJI.
Yangmengfan Chen, Hao Du, Heng Sun and 7 more — Nature Communications
Peer-reviewed journalBold claims, read criticallyReal-world use